Will Probiotics Be a Game Changer in the Treatment of Recurrent UTI? – A Short Review
DOI:
https://doi.org/10.56570/jimgs.v2i2.105Keywords:
Recurrent urinary tract infection, Probiotics, Lactobacillus, Drug Resistance, microbiota, Antibiotic ProphylaxisAbstract
The most frequent condition primary care doctors address is recurrent urinary tract infections (RUTI) in both men and women. RUTI is defined as occurring at least three times in the past year or twice in the past six months. This is a serious health hazard for women. Even though there is a wide range of antibiotics available for the treatment of bacterial urinary tract infections (UTIs), due to the development of antibiotic resistance, chronic UTIs are now the subject of debate. This review focuses on the connection between probiotic use and the management of recurrent UTIs and offers recommendations for using probiotics as a substitute to lessen the likelihood of adverse medication reactions. After reviewing a number of studies, it was determined that probiotics might be a better choice than antibiotics given their advantages over disadvantages.References
Harding C, Rantell A, Cardozo L, et al. How can we improve investigation, prevention and treatment for recurrent urinary tract infections - ICI-RS 2018. Neurourol Urodyn. 2019;38 Suppl 5:S90-S97. doi:10.1002/nau.24021
Ennis SS, Guo H, Raman L, Tambyah PA, Chen SL, Tiong HY. Premenopausal women with recurrent urinary tract infections have lower quality of life. Int J Urol. 2018;25(7):684-689. doi:10.1111/iju.13698
Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7(12):653-660. doi:10.1038/nrurol.2010.190
Rich SN, Klann EM, Almond CR, Larkin EM, Nicolette G, Ball JD. Associations between antibiotic prescriptions and recurrent urinary tract infections in female college students. Epidemiol Infect. 2019;147:e119. doi:10.1017/S0950268818003369
Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28(1):1-13. doi:10.1016/j.idc.2013.09.003
Wagenlehner F, Wullt B, Ballarini S, Zingg D, Naber KG. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT). Expert Rev Pharmacoecon Outcomes Res. 2018;18(1):107-117. doi:10.1080/14737167.2017.1359543
Pilatz A, Veeratterapillay R, Dimitropoulos K, et al. European Association of Urology Position Paper on the Prevention of Infectious Complications Following Prostate Biopsy. Eur Urol. 2021;79(1):11-15. doi: 10.1016/j.eururo.2020.10.019
Cai T. Recurrent uncomplicated urinary tract infections: definitions and risk factors. GMS Infect Dis. 2021;9: Doc03. Published 2021 May 27. doi:10.3205/id000072
Lecky DM, Howdle J, Butler CC, McNulty CA. Optimising management of UTIs in primary care: a qualitative study of patient and GP perspectives to inform the development of an evidence-based, shared decision-making resource. Br J Gen Pract. 2020;70(694):e330-e338. Published 2020 Apr 30. doi:10.3399/bjgp20X708173
Lüthje P, Brauner H, Ramos NL, et al. Estrogen supports urothelial defense mechanisms. Sci Transl Med. 2013;5(190):190ra80. doi:10.1126/scitranslmed.3005574
Clayson D, Wild D, Doll H, Keating K, Gondek K. Validation of a patient-administered questionnaire to measure the severity and bothersomeness of lower urinary tract symptoms in uncomplicated urinary tract infection (UTI): the UTI Symptom Assessment questionnaire. BJU Int. 2005;96(3):350-359. doi:10.1111/j.1464-410X.2005.05630.x
Flores-Mireles AL, Walker JN, Caparon M et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature reviews.2013. Microbiology. 13(5), 269–284. https://doi.org/10.1038/nrmicro3432
Glover M, Moreira CG, Sperandio V, Zimmern P. Recurrent urinary tract infections in healthy and nonpregnant women. Urol Sci. 2014;25(1):1-8. doi:10.1016/j.urols.2013.11.007
Gupta V, Nag D, Garg P. Recurrent urinary tract infections in women: How promising is the use of probiotics?. Indian J Med Microbiol. 2017;35(3):347-354. doi:10.4103/ijmm.IJMM_16_292
Alidjanov JF, Naber KG, Abdufattaev UA, Pilatz A, Wagenlehner FME. Reevaluation of the Acute Cystitis Symptom Score, a Self-Reporting Questionnaire. Part I. Development, Diagnosis and Differential Diagnosis. Antibiotics (Basel). 2018;7(1):6. Published 2018 Jan 15. doi:10.3390/antibiotics7010006
Sha BE, Zariffard MR, Wang QJ, et al. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis. 2005;191(1):25-32. doi:10.1086/426394
Reid G, Burton J, Devillard E. The rationale for probiotics in female urogenital healthcare. MedGenMed. 2004;6(1):49. Published 2004 Mar 29.
Humen MA, De Antoni GL, Benyacoub J, et al. Lactobacillus johnsonii La1 antagonizes Giardia intestinalis in vivo. Infect Immun. 2005;73(2):1265-1269. doi:10.1128/IAI.73.2.1265-1269.2005
Antonio MA, Rabe LK, Hillier SL. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. The Journal of infectious diseases,2005;192(3), 394–398. doi.org/10.1086/430926
20. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis. 2006;6(6):374-382. doi:10.1016/S1473-3099(06)70495-9
Gupta K, Stapleton AE, Hooton TM, Roberts PL, Fennell CL, Stamm WE. Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis. 1998;178(2):446-450. doi:10.1086/515635
Wolfe AJ, Toh E, Shibata N, et al. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol. 2012;50(4):1376-1383. doi:10.1128/JCM.05852-11
Siddiqui H, Nederbragt AJ, Lagesen K. et al. Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol.2011;11, 244. doi.org/10.1186/1471-2180-11-244
Pearce MM, Hilt EE, Rosenfeld AB, et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio. 2014;5(4):e01283-14. Published 2014 Jul 8. doi:10.1128/mBio.01283-14
Akgül T, Karakan T. The role of probiotics in women with recurrent urinary tract infections. Turk J Urol. 2018;44(5):377-383. doi:10.5152/tud.2018.48742
Abad CL, Safdar N.The role of lactobacillus probiotics in the treatment or prevention of urogenital infections--a systematic review. Journal of chemotherapy (Florence, Italy).2009; 21, 243–252. doi.org/10.1179/joc.2009.21.3.243
Beerepoot MA, ter Riet G, Nys S, et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012;172(9):704-712. doi:10.1001/archinternmed.2012.777
Beerepoot M, Geerlings S. Non-Antibiotic Prophylaxis for Urinary Tract Infections. Pathogens. 2016;5(2):36. Published 2016 Apr 16. doi:10.3390/pathogens5020036
Zuccotti GV, Meneghin F, Raimondi C, et al. Probiotics in clinical practice: an overview. J Int Med Res. 2008;36 Suppl 1:1A-53A. doi:10.1177/14732300080360S101
Meena J, Thomas CC, Kumar J, Raut S, Hari P. Non-antibiotic interventions for prevention of urinary tract infections in children: a systematic review and meta-analysis of randomized controlled trials. Eur J Pediatr. 2021;180(12):3535-3545. doi:10.1007/s00431-021-04091-2
Sadeghi-Bojd S, Naghshizadian R, Mazaheri M, et al. Efficacy of Probiotic Prophylaxis After the First Febrile Urinary Tract Infection in Children with Normal Urinary Tracts. Journal of the Pediatric Infectious Diseases Society. 2020. 9(3), 305–310. https://doi.org/10.1093/jpids/piz025
Reid G, Charbonneau D, Erb J, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. 2003. FEMS immunology and medical microbiology. 35(2), 131–134. https://doi.org/10.1016/S0928-8244(02)00465-0
